Immobilization of urokinase on the islet surface by amphiphilic poly(vinyl alcohol) that carries alkyl side chains

Biomaterials

Volumn 29, Issue 19, 2008, Pages 2878-2883

  Totani, Takahiko ^a   Teramura, Yuji ^b   Iwata, Hiroo ^a  

^a KYOTO UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

Islet; Poly(vinyl alcohol); Surface modification; Transplantation; Urokinase

Indexed keywords

COAGULATION; IMMUNOLOGY; INSULIN; POLYVINYL ALCOHOLS; SURFACE REACTIONS; SURFACE TREATMENT; TRANSPLANTATION (SURGICAL);

IMMUNOLOGICAL REACTIONS; UROKINASE;

ENZYME IMMOBILIZATION;

ALKYL GROUP; AMPHOPHILE; MALEIMIDE; PLASMINOGEN ACTIVATOR; POLYVINYL ALCOHOL; THIOL; UROKINASE;

ARTICLE; BLOOD CLOTTING; CHEMICAL BINDING; ENZYME IMMOBILIZATION; FIBRINOLYSIS; GRAFT FAILURE; HUMAN; HUMAN CELL; INNATE IMMUNITY; INSULIN DEPENDENCE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; LIPID BILAYER; ORGAN DONOR; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; RECIPIENT; SURFACE PROPERTY;

CELL LINE; GLUCOSE; HUMANS; ISLETS OF LANGERHANS; POLYVINYL ALCOHOL; URINARY PLASMINOGEN ACTIVATOR;

EID: 42249088412     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2008.03.024     Document Type: Article

References (27)

1. Ryan E.A., Lakey J.R., Rajotte R.V., Korbutt G.S., Kin T., Imes S., et al. Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol. Diabetes 50 (2001) 710-719
2. Shapiro A.M., Lakey J.R., Ryan E.A., Korbutt G.S., Toth E., Warnock G.L., et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 343 (2000) 230-238
3. Ryan E.A., Paty B.W., Senior P.A., Bigam D., Alfadhli E., Kneteman N.M., et al. Five-year follow-up after clinical islet transplantation. Diabetes 54 (2005) 2060-2069
4. Bennet W., Groth C.G., Larsson R., Nilsson B., and Korsgren O. Isolated human islets trigger an instant blood mediated inflammatory reaction: implications for intraportal islet transplantation as a treatment for patients with type 1 diabetes. Ups J Med Sci 105 (2000) 125-133
5. Johansson H., Lukinius A., Moberg L., Lundgren T., Berne C., Foss A., et al. Tissue factor produced by the endocrine cells of the islets of Langerhans is associated with a negative outcome of clinical islet transplantation. Diabetes 54 (2005) 1755-1762
6. Berman D.M., Cabrera O., Kenyon N.M., Miller J., Tam S.H., Khandekar V.S., et al. Interference with tissue factor prolongs intrahepatic islet allograft survival in a nonhuman primate marginal mass model. Transplantation 84 (2007) 308-315
7. Rood P.P., Bottino R., Balamurugan A.N., Smetanka C., Ayares D., Groth C.G., et al. Reduction of early graft loss after intraportal porcine islet transplantation in monkeys. Transplantation 83 (2007) 202-210
8. Johansson H., Goto M., Dufrane D., Siegbahn A., Elgue G., Gianello P., et al. Low molecular weight dextran sulfate: a strong candidate drug to block IBMIR in clinical islet transplantation. Am J Transplant 6 (2006) 305-312
9. Ozmen L., Ekdahl K.N., Elgue G., Larsson R., Korsgren O., and Nilsson B. Inhibition of thrombin abrogates the instant blood-mediated inflammatory reaction triggered by isolated human islets islets: possible application of the thrombin inhibitor melagatran in clinical islet transplantation. Diabetes 51 (2002) 1779-1784
10. Beuneu C., Vosters O., Ling Z., Pipeleers D., Pradier O., Goldman M., et al. N-Acetylcysteine derivative inhibits procoagulant activity of human islet cells. Diabetologia 50 (2007) 343-347
11. Cabric S., Sanchez J., Lundgren T., Foss A., Felldin M., Källen R., et al. Islet surface heparinization prevents the instant blood-mediated inflammatory reaction in islet transplantation. Diabetes 56 (2007) 2008-2015
12. Miura S., Teramura Y., and Iwata H. Encapsulation of islets with ultra-thin polyion complex membrane through poly(ethylene glycol)-phospholipids anchored to cell membrane. Biomaterials 27 (2006) 5828-5835
13. Teramura Y., Kaneda Y., Totani T., and Iwata H. Behavior of synthetic polymers immobilized on a cell membrane. Biomaterials 29 (2008) 1345-1355
14. Teramura Y., Kaneda Y., and Iwata H. Islet-encapsulation in ultra-thin layer-by-layer membranes of poly(vinyl alcohol) anchored to poly(ethylene glycol)-lipids in the cell membrane. Biomaterials 28 (2007) 4818-4825
15. Vassalli J.D., Sappino A.P., and Belin D. The plasminogen activator/plasmin system. J Clin Invest 88 (1991) 1067-1072
16. Hosono M., Sugii S., Kitamaru R., and Man-Hong Y. Polyelectrolyte complex prepared from carboxymethylated and aminoacetalized derivatives of poly(vinyl alcohol). J Appl Polym Sci 21 (1977) 2125-2134
17. Benjamin W.G., Hamilton D.D., Sara S., and Kristin B. A short synthesis of an acetylenic alcohol from the sponge Cribrochalina vasculum. Synth Commun 32 (2002) 2733-2740
18. Gossage J.A., Humphries J., Modarai B., Burnand K.G., and Smith A. Adenoviral urokinase-type plasminogen activator (uPA) gene transfer enhances venous thrombus resolution. J Vasc Surg 44 (2006) 1085-1090
19. Virji M.A., and Dimasi M.J. Selective secretion of only the urokinase plasminogen activator from rat islets of Langerhans. Diabetes Res 6 (1987) 9-13
20. Stabler C.L., Sun X.L., Cui W., Wilson J.T., Haller C.A., and Chaikof E.L. Surface re-engineering of pancreatic islets with recombinant azido-thrombomodulin. Bioconjug Chem 18 (2007) 1713-1715
21. Lim F., and Sun A.M. Microencapsulated islets as bioartificial endocrine pancreas. Science 210 (1980) 908-910
22. Iwata H., Takagi T., Amemiya H., Shimizu H., Yamashita K., Kobayashi K., et al. Agarose for a bioartificial pancreas. J Biomed Mater Res 26 (1992) 967-977
23. Murakami M., Satou H., Kimura T., Kobayashi T., Yamaguchi A., Nakagawara G., et al. Effects of micro-encapsulation on morphology and endocrine function of cryopreserved neonatal porcine islet-like cell clusters. Transplantation 70 (2000) 1143-1148
24. Xu B.Y., Yang H., Serreze D.V., MacIntosh R., Yu W., and Wright Jr. J.R. Rapid destruction of encapsulated islet xenografts by NOD mice is CD4-dependent and facilitated by B-cells: innate immunity and autoimmunity do not play significant roles. Transplantation 80 (2005) 402-429
25. Calafiore R., Basta G., Luca G., Lemmi A., Montanucci M.P., Calabrese G., et al. Microencapsulated pancreatic islet allografts into nonimmunosuppressed patients with type 1 diabetes: first two cases. Diabetes Care 29 (2006) 137-138
26. Wyman J.L., Kizilel S., Skarbek R., Zhao X., Connors M., Dillmore W.S., et al. Immunoisolating pancreatic islets by encapsulation with selective withdrawal. Small 3 (2007) 683-690
27. Krol S., del Guerra S., Grupillo M., Diaspro A., Gliozzi A., and Marchetti P. Multilayer nanoencapsulation. New approach for immune protection of human pancreatic islets. Nano Lett 6 (2006) 1933-1939